Can a heart drug protect dialysis patients from deadly cardiovascular events?
NCT ID NCT01475123
First seen Nov 01, 2025 · Last updated Jun 11, 2026 · Updated 36 times
Summary
This study tests whether a drug called nicorandil can reduce the risk of heart attacks, strokes, and other serious heart problems in people with coronary artery disease who are on dialysis. The trial involves 268 participants and compares those taking nicorandil to those not taking it. The goal is to see if this medication can help manage heart disease in this high-risk group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University
Kumamoto, 860-8556, Japan
Conditions
Explore the condition pages connected to this study.